![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gadelha Ary Noto Cristiano Souza de Jesus Mari Jair
Publisher: Informa Healthcare
ISSN: 1369-1627
Source: International Review of Psychiatry, Vol.24, Iss.5, 2012-10, pp. : 489-498
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel pharmacological approaches to the treatment of schizophrenia
Nordic Journal of Psychiatry, Vol. 54, Iss. 4, 2000-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Toxic Psychoses as Pharmacological Models of Schizophrenia
Current Psychiatry Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PET studies in schizophrenia: Functional and pharmacological studies
By Gefvert Ola
Nordic Journal of Psychiatry, Vol. 54, Iss. 4, 2000-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Aripiprazole: a new treatment for schizophrenia
Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. :